Vaccine effectiveness in patients admitted for influenza during the 2023-2024 season

被引:0
|
作者
Martinez, Christian Ruzafa [1 ,2 ,3 ]
Valero, Salvador [1 ,2 ,3 ]
Villalba, Eva Garcia [1 ,2 ,3 ]
Tomas, Cristina [1 ,2 ,3 ]
Munoz, Angeles [1 ,2 ,3 ]
Alcaraz, Antonia [1 ,2 ,3 ]
Martinez-Rodriguez, Rodrigo [1 ,2 ,3 ]
Hernandez, Maria Dolores [1 ,2 ,3 ]
Martinez, Maria Isabel [1 ,2 ,3 ]
Vicente, Maria Rosario [4 ]
Westermeyer, Elena Guijarro [1 ,2 ,3 ]
Hipolito, Roman Gonzalez [1 ,2 ,3 ]
Bernal, Enrique [1 ,2 ,3 ]
机构
[1] Hosp Gen Univ Reina Sofia, Secc Enfermedades Infecciosas, Murcia, Spain
[2] Inst Murciano Invest Biosanitaria Pascual Parrilla, Inmunol Microbiol & Enfermedades Infecciosas, Murcia, Spain
[3] Univ Murcia, Fac Med, Dept Med Interna, Murcia, Spain
[4] Hosp Gen Univ Reina Sofia, Serv Microbiol, Murcia, Spain
来源
MEDICINA CLINICA | 2024年 / 163卷 / 12期
关键词
Flu; Vaccine; Effectiveness; Intensive Care; Mortality;
D O I
10.1016/j.medcli.2024.07.023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and goal: Vaccination against influenza is widespread worldwide, reducing complications associated with infection. However, the impact of vaccination on mortality/ICU admission in hospitalized patients has been little studied. Material and methods: A retrospective observational study was conducted on 238 patients hospitalized for influenza from October 2023 to January 2024 to evaluate the vaccine's effectiveness in terms of the combined event of ICU admission/mortality during hospitalization. Additionally, the characteristics of vaccinated patients and the existence of bacterial superinfection were analyzed. Cox regression was performed using the SPSS program and the free << R >> software. Results: A total of 238 patients were included. Those vaccinated were older (78.2 f 8.8 vs 69.97 f 16.6 years; P < .001) and were more likely to have hypertension (82.2% vs 56.2%; P < .001), cardiovascular disease (36.6% vs 24.1%; P = .05), chronic bronchopathy (25.7% vs 8.8%; P = .001), or chronic kidney disease (22.8% vs 8.8%; P = 0.005). They had lower levels of CRP (8.39 f 9.55 vs 11.03 f 10.75 mg/dl; P = .05), procalcitonin (0.62 f 1.74 vs 1.67 f 4.57 ng/dl; P = .05), and SOFA scores (1.13 f 0.9 vs 1.39 f 0.97; P = 0.033). 11 patients were admitted to ICU (4.6%) and 11 died (4.6%). Influenza vaccination was associated as a protective factor against ICU admission/mortality in the Cox regression (HR = 0.216; 95% CI: 0.0620.759, P = .017). The presence of bacterial superinfection was similar between vaccinated and unvaccinated patients (63.4% vs 67.9%; P = .556). Conclusions: Influenza vaccination may reduce the probability of ICU admission or death. This effect is likely due to better control of the immune response. We did not observe any relationship with the risk of presenting bacterial superinfection. (c) 2024 Elsevier Espana, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:589 / 594
页数:6
相关论文
共 50 条
  • [31] Respiratory Syncytial Virus and Other Respiratory Viruses in Hospitalized Infants During the 2023-2024 Winter Season in Mexico
    Leija-Martinez, Jose J.
    Cadena-Mota, Sandra
    Gonzalez-Ortiz, Ana Maria
    Munoz-Escalante, Juan Carlos
    Mata-Moreno, Gabriel
    Hernandez-Sanchez, Pedro Gerardo
    Vega-Morua, Maria
    Noyola, Daniel E.
    VIRUSES-BASEL, 2024, 16 (12):
  • [32] Influenza vaccine effectiveness against medically-attended influenza infection in 2023/24 season in Hangzhou, China
    Lei, Hao
    Niu, Beidi
    Sun, Zhou
    Wang, Yaojing
    Che, Xinren
    Du, Shengqiang
    Liu, Yan
    Zhang, Ke
    Zhao, Shi
    Yang, Shigui
    Wang, Zhe
    Zhao, Gang
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2025, 21 (01)
  • [33] Effectiveness of inactivated influenza vaccine in children during the 2023/ 24 season: The first season after relaxation of intensive COVID-19 measures
    Shinjoh, Masayoshi
    Yaginuma, Mizuki
    Yamaguchi, Yoshio
    Tamura, Kazuyo
    Furuichi, Munehiro
    Tsumura, Yuki
    Itaki, Ryo
    Iqbal, Asef
    Maeda, Naonori
    Narabayashi, Atsushi
    Kamei, Akinobu
    Shibata, Akimichi
    Yamada, Go
    Nishida, Mitsuhiro
    Kenichiro, Tsunematsu
    Chiga, Michiko
    Shimoyamada, Motoko
    Yoshida, Makoto
    Fukushima, Naoya
    Nakata, Yuji
    Fukushima, Hiroyuki
    Kawakami, Chiharu
    Narumi, Satoshi
    Sugaya, Norio
    VACCINE, 2024, 42 (23)
  • [34] Pregnant persons perceptions and uptake of prenatal RSV vaccine - Minnesota, 2023-2024
    Desilva, Malini B.
    Vazquez-Benitez, Gabriela
    Seburg, Elisabeth M.
    Henderson, Maren S. G.
    Ehresmann, Kirsten
    Zibley, Laura J.
    Palmsten, Kristin
    VACCINE, 2025, 54
  • [35] Influenza incidence and vaccine effectiveness during the Southern Hemisphere Influenza season-Chile, 2022
    Olivares Barraza, Maria Fernanda
    Fasce, Rodrigo A.
    Nogareda, Francisco
    Marcenac, Perrine
    Mallegas, Natalia Vergara
    Bustos Alister, Patricia
    Loayza, Sergio
    Chard, Anna N.
    Sofia Arriola, Carmen
    Couto, Paula
    Garcia Calavaro, Christian
    Rodriguez, Angel
    Wentworth, David E.
    Cuadrado, Cristobal
    Azziz-Baumgartner, Eduardo
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 (12) : 3170 - 3174
  • [36] Respiratory Virus Season Surveillance in the United States Using Wastewater Metrics, 2023-2024
    Chan, Elana M. G.
    Boehm, Alexandria B.
    ACS ES&T WATER, 2025,
  • [37] Influenza Vaccine Effectiveness in the United States during the 2015-2016 Season
    Jackson, Michael L.
    Chung, Jessie R.
    Jackson, Lisa A.
    Phillips, C. Hallie
    Benoit, Joyce
    Monto, Arnold S.
    Martin, Emily T.
    Belongia, Edward A.
    McLean, Huong Q.
    Gaglani, Manjusha
    Murthy, Kempapura
    Zimmerman, Richard
    Nowalk, Mary P.
    Fry, Alicia M.
    Flannery, Brendan
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (06): : 534 - 543
  • [38] Interim estimation of influenza vaccine effectiveness during the 2007-08 season
    Belongia, Edward
    Kieke, Burney
    Donahue, James
    Coleman, Laura
    Meece, Jennifer
    Lindstrom, Stephen
    Shay, David
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S195 - S195
  • [39] Influenza Vaccine Effectiveness in the United States During the 2016-2017 Season
    Flannery, Brendan
    Chung, Jessie R.
    Monto, Arnold S.
    Martin, Emily T.
    Belongia, Edward A.
    McLean, Huong Q.
    Gaglani, Manjusha
    Murthy, Kempapura
    Zimmerman, Richard K.
    Nowalk, Mary Patricia
    Jackson, Michael L.
    Jackson, Lisa A.
    Rolfes, Melissa A.
    Spencer, Sarah
    Fry, Alicia M.
    Petrie, Joshua G.
    Malosh, Ryan E.
    McSpadden, E. J.
    Segaloff, Hannah E.
    Cheng, Caroline K.
    Truscon, Rachel
    Johnson, Emileigh
    Lamerato, Lois E.
    Ivacic, Lynn C.
    King, Jennifer P.
    Meece, Jennifer K.
    Palmquist, Madalyn M.
    Guzinski, Sherri A.
    Robertson, Anne
    Kossie, Ashley
    Smith, Michael
    Hoelscher, Vanessa
    Clipper, Lydia
    Walker, Kimberley
    Volz, Marcus
    Rao, Arundhati
    Fader, Robert
    Munoz-Maldonado, Yolanda
    Reis, Michael
    Williams, John V.
    Balasubramani, Goundappa K.
    Reis, Evelyn C.
    Eng, Heather
    Ford, Samantha
    Bear, Todd M.
    Ricci, Edmund M.
    Hickey, Robert W.
    Moehling, Krissy K.
    Raviotta, Jonathan M.
    Sax, Theresa M.
    CLINICAL INFECTIOUS DISEASES, 2019, 68 (11) : 1798 - 1806
  • [40] Impact of caregiver vaccination status on child influenza vaccination hesitancy: A time-to-vaccination analysis for 2023-2024 season in the Republic of Korea
    Kim, So-Yeon
    Song, Minju
    Kwon, Seunghyun Lewis
    VACCINE, 2025, 49